Downloads provided by UsageCounts
The detection of circulating tumor cells (CTCs) in the blood of cancer patients has been correlated with bad prognosis and therapy resistance. however, finding CTCs in peripheral blood is challenging due to their low number. we have developed the RUBYchipTM, a microfluidic device that isolates CTCs from whole blood of patients with outstanding capture efficiency (>70%). to bring CTCs to the clinical routine it is necessary to define pre-analytical parameters to comply with new IVD regulation and assure reproducible results across laboratories. In this publication, we investigate the effect of blood sample preservation and storage on CTC isolation efficiency using the RUBYchipTM.
https://inl.int/wp-content/uploads/2022/02/booklet-of-abstracts-1.pdf
Circulating Tumor cells, liquid biopsy, microfluidics
Circulating Tumor cells, liquid biopsy, microfluidics
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 2 | |
| downloads | 39 |

Views provided by UsageCounts
Downloads provided by UsageCounts